Chronic illness sees a spurt in business opportunity for Indian pharma market – The Economic Times

The last five years have seen the highest volume growth in anti-diabetic medicines followed by those for treating semi-chronic ailments in urology urinary-related and dermatology skin care. According to data from industry body AIOCD, the Indian pharma market grew at a compound annual growth rate of 3.3 per cent in volume terms in the past five years. Against this, medicines for combating diabetes, urology and dermatological ailments have grown at more than double the industry growth rate.

Read more – The Economic Times